Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12449-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- MEOX2 antibody
- Antibody type
- Polyclonal
- Description
- MEOX2 antibody (Cat. #12449-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references RING Finger Protein 10 Regulates AP-1/Meox2 to Mediate Pirarubicin-Induced Cardiomyocyte Apoptosis.
Ring finger protein 10 improves pirarubicin-induced cardiac inflammation by regulating the AP-1/Meox2 signaling pathway.
circINSR Inhibits Adipogenic Differentiation of Adipose-Derived Stromal Vascular Fractions through the miR-152/MEOX2 Axis in Sheep.
Mesenchyme homeobox 2 has a cancer-inhibiting function in breast carcinoma via affection of the PI3K/AKT/mTOR and ERK1/2 pathways.
Shi H, Duan L, Lan Y, He Q, Pu P, Tang H
Oxidative medicine and cellular longevity 2023;2023:7872193
Oxidative medicine and cellular longevity 2023;2023:7872193
Ring finger protein 10 improves pirarubicin-induced cardiac inflammation by regulating the AP-1/Meox2 signaling pathway.
Duan L, Tang H, Lan Y, Shi H, Pu P, He Q
Toxicology and applied pharmacology 2023 Mar 1;462:116411
Toxicology and applied pharmacology 2023 Mar 1;462:116411
circINSR Inhibits Adipogenic Differentiation of Adipose-Derived Stromal Vascular Fractions through the miR-152/MEOX2 Axis in Sheep.
Zhao B, Zhang H, Zhao D, Liang Y, Qiao L, Liu J, Pan Y, Yang K, Liu W
International journal of molecular sciences 2023 Feb 9;24(4)
International journal of molecular sciences 2023 Feb 9;24(4)
Mesenchyme homeobox 2 has a cancer-inhibiting function in breast carcinoma via affection of the PI3K/AKT/mTOR and ERK1/2 pathways.
Cai Y, Liu Y, Sun Y, Ren Y
Biochemical and biophysical research communications 2022 Feb 19;593:20-27
Biochemical and biophysical research communications 2022 Feb 19;593:20-27
No comments: Submit comment
No validations: Submit validation data